Two enzymes from the protein disulphide isomerase (PDI) family enable prostate cancer cells to grow, survive, and resist treatment. This discovery, however, could be taken as an advantage to improve ...

Doctors have long looked to the hormone testosterone as a piece of the prostate cancer puzzle. The man on the other end was J. Bruce Hunsicker, an Akron-based lawyer with prostate cancer who had ...

Prostate cancer affects one in eight men in the U.S. over their lifetime, which is the same rate as women and breast cancer.

Much of the challenge in developing cancer therapies is determining methods to improve the effectiveness of the immune system’s ability to identify and kill cancer cells. While therapies like CAR T ...

SBRT Delays Systemic Therapy in Oligometastatic Cancers For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently delay the need for ...

Prostate cancer kills more than 12,000 men a year in the UK, slightly more than the number of women who die from breast cancer.

The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily?